Strategic Partnerships RCT has a track record of partnering with capital providers like BroadOak Capital Partners and recently with Codis for growth investments, signaling openness to co-investment opportunities and multi-party funding arrangements that can be leveraged for new life science portfolio companies.

Life Sciences Focus The firm concentrates on life sciences, medical devices, and therapeutics development, suggesting a target market for selling specialized financial services, advisory, and capital solutions tailored to early-stage to growth-stage biotech and medtech ventures.

End-to-End Expertise RCT offers comprehensive support from company formation, IP strategy, licensing, literature searches, to marketing support, creating a compelling value proposition for startups seeking holistic financial and strategic guidance.

Growth Investment Activity Recent investments and growth financing activity, including Codis and ongoing partnerships, indicate a receptive posture toward scalable funding rounds and expansion-focused services that can be proposed to portfolio companies.

Technology Enablement Utilization of a broad tech stack and emphasis on patenting, licenses, and literature searches points to opportunities to sell enhanced IP management, diligence, and compliance tools, as well as marketing and analytics services to portfolio firms.